AAAAAA

   
Results: 1-9 |
Results: 9
Serum iron indices as a measure of iron deposits in chronic hepatitis C
Authors: Fabris, C Toniutto, P Scott, CA Falleti, E Avellini, C Del Forno, M Mattiuzzo, M Branca, B Pirisi, M
Citation: C. Fabris et al., Serum iron indices as a measure of iron deposits in chronic hepatitis C, CLIN CHIM A, 304(1-2), 2001, pp. 49-55
Iron deposition and progression of disease in chronic hepatitis C - Role of interface hepatitis, portal inflammation, and HFE missense mutations
Authors: Pirisi, M Scott, CA Avellini, C Toniutto, P Fabris, C Soardo, G Beltrami, CA Bartoli, E
Citation: M. Pirisi et al., Iron deposition and progression of disease in chronic hepatitis C - Role of interface hepatitis, portal inflammation, and HFE missense mutations, AM J CLIN P, 113(4), 2000, pp. 546-554
Evaluation of circulating activin-A as a serum marker of hepatocellular carcinoma
Authors: Pirisi, M Fabris, C Luisi, S Santuz, M Toniutto, P Vitulli, D Federico, E Del Forno, M Mattiuzzo, M Branca, B Petraglia, F
Citation: M. Pirisi et al., Evaluation of circulating activin-A as a serum marker of hepatocellular carcinoma, CANCER DET, 24(2), 2000, pp. 150-155
Carriage of HFE mutations and outcome of surgical resection for hepatocellular carcinoma in cirrhotic patients
Authors: Pirisi, M Toniutto, P Uzzau, A Fabris, C Avellini, C Scott, C Apollonio, L Beltrami, CA Bresadola, F
Citation: M. Pirisi et al., Carriage of HFE mutations and outcome of surgical resection for hepatocellular carcinoma in cirrhotic patients, CANCER, 89(2), 2000, pp. 297-302
Immunoreactivity to putative B-cell epitopes of hepatitis G virus polyprotein in viremic and nonviremic subjects
Authors: Toniutto, P Fabris, C Barbone, F Tisminetzky, SG Liani, D Galai, T Barillari, G Biffoni, F Gasparini, V Pirisi, M
Citation: P. Toniutto et al., Immunoreactivity to putative B-cell epitopes of hepatitis G virus polyprotein in viremic and nonviremic subjects, CL DIAG LAB, 6(4), 1999, pp. 573-576
IgM antibody response to the hepatitis C virus core protein in intravenousdrug users
Authors: Toniutto, P Falleti, E Gasparini, V Fabris, C Tisminetzky, SG Lombardelli, T Pacco, P Satta, A Pirisi, M
Citation: P. Toniutto et al., IgM antibody response to the hepatitis C virus core protein in intravenousdrug users, DIAG MICR I, 33(2), 1999, pp. 69-73
A study on the role of the family and other risk factors in HCV transmission
Authors: Brusaferro, S Barbone, F Andrian, P Brianti, G Ciccone, L Furlan, A Gnesutta, D Stel, S Zamparo, E Toniutto, P Ferroni, P Gasparini, V
Citation: S. Brusaferro et al., A study on the role of the family and other risk factors in HCV transmission, EUR J EPID, 15(2), 1999, pp. 125-132
Kinetics of serum soluble tumour necrosis factor receptor (TNF-R) type-I and type-II after a single interferon-alpha (IFN-alpha) injection in chronichepatitis C
Authors: Fabris, C Del Forno, M Falleti, E Toniutto, P Pirisi, M
Citation: C. Fabris et al., Kinetics of serum soluble tumour necrosis factor receptor (TNF-R) type-I and type-II after a single interferon-alpha (IFN-alpha) injection in chronichepatitis C, CLIN EXP IM, 117(3), 1999, pp. 556-560
Evidence against a direct role played by transfusion-transmitted virus infection in causing hepatic or hematologic manifestations
Authors: Toniutto, P Fabris, C Falleti, E Lombardelli, T Gasparini, V Barillari, G Biffoni, F Pirisi, M
Citation: P. Toniutto et al., Evidence against a direct role played by transfusion-transmitted virus infection in causing hepatic or hematologic manifestations, BLOOD, 93(7), 1999, pp. 2426-2427
Risultati: 1-9 |